Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-19

Clinical Trial Update: Hydroxychloroquine in ANCA Vasculitis Evaluation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating hydroxychloroquine for ANCA-associated vasculitis, including microscopic polyangiitis, eosinophilic granulomatosis with polyangi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: ANCA Associated Vasculitis, Microscopic Polyangiitis | Phase 4 | Status: UNKNOWN